Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

Author： Pasquali Renato   Gambineri Alessandra  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.10, 2009-10, pp. : 1205-1226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of polycystic ovary syndrome with insulin-lowering agents

By Wang Ping   Streicher Patricia   Glueck Charles J  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1177-1189

Informa Healthcare

Access to resources Recommend Favorite

Insulin-sensitisers in the treatment of polycystic ovary syndrome

By Teede Helena J   Meyer C   Norman RJ  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2419-2427

Informa Healthcare

Access to resources Recommend Favorite

Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome

By Yildiz Bulent O   Gedik Olcay  

Reproductive BioMedicine Online, Vol. 8, Iss. 6, 2004-06 ,pp. : 649-656

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-11 ,pp. : 5526-5534

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

By Katsiki Niki   Georgiadou Eleni   Hatzitolios Apostolos I.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1417-1431

Adis International

Access to resources Recommend Favorite